Anticipated Classes of New Medications and Molecular Targets for Pulmonary Arterial Hypertension

Abstract excerpt

Pulmonary arterial hypertension (PAH) remains a life-limiting condition with a major impact on the ability to lead a normal life. Although existing therapies may improve the outlook in some patients there remains a major unmet need to develop more effective therapies in this condition. There have been significant advances in our understanding of the genetic, cell and molecular basis of PAH over the last few...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Circular RNAs in diseases
• Share to MicroRNA in disease regulation
• Share to Pulmonary Hypertension Research and Treatments